Literature DB >> 8619008

Diazepam prevents progression of kindled alcohol withdrawal behaviour.

J Ulrichsen1, B Bech, P Allerup, R Hemmingsen.   

Abstract

The purpose of the present experiment was to study the "kindling" hypothesis of alcohol withdrawal stating that exposure to repeated episodes of alcohol withdrawal results in an increased severity of subsequent withdrawal reactions. Two groups of male Wistar rats were subjected to 13 episodes of 2 days severe alcohol intoxication and 5 days alcohol withdrawal. Animals in the control group (n = 80) developed clinical withdrawal signs following each intoxication episode. In the diazepam group (n = 80) the withdrawal reactions during episodes 1-9 were blocked by intraperitoneal diazepam administration (0-30 mg/kg) 8, 11 and 15 h into withdrawal. During episode 10-13 diazepam treatment was terminated and convulsive withdrawal behaviour was observed 9-15 h after last alcohol dose. The probability of seizure activity during these four withdrawal episodes was calculated as 0.239 and 0.066 in the control and the diazepam groups, respectively. Based on Monte Carlo simulation techniques, this difference was found to be statistically significant (P < 0.05). No differences in the non-convulsive alcohol withdrawal symptoms tremor, hyperactivity and rigidity were detected between controls and diazepam animals after diazepam treatment. It was concluded that the increased convulsive behaviour in the control group was caused by cumulated kindling-like cerebral alterations during the previous repeated alcohol withdrawal phases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8619008     DOI: 10.1007/bf02246493

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  30 in total

1.  Generality of the kindling phenomenon: some clinical implications.

Authors:  J P Pinel; P H Van Oot
Journal:  Can J Neurol Sci       Date:  1975-11       Impact factor: 2.104

2.  The GABA/benzodiazepine receptor chloride channel complex during repeated episodes of physical ethanol dependence in the rat.

Authors:  J Ulrichsen; L Clemmesen; D Barry; R Hemmingsen
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 3.  Kindling as a model for alcohol withdrawal syndromes.

Authors:  J C Ballenger; R M Post
Journal:  Br J Psychiatry       Date:  1978-07       Impact factor: 9.319

Review 4.  Delirium tremens and related clinical states: psychopathology, cerebral pathophysiology and psychochemistry: a two-component hypothesis concerning etiology and pathogenesis.

Authors:  R Hemmingsen; P Kramp
Journal:  Acta Psychiatr Scand Suppl       Date:  1988

5.  Physical dependence on ethanol during multiple intoxication and withdrawal episodes in the rat: evidence of a potentiation.

Authors:  L Clemmesen; R Hemmingsen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1984-11

6.  Cerebral metabolic state during the ethanol withdrawal reaction in the rat.

Authors:  R Hemmingsen; A G Chapman
Journal:  J Neurochem       Date:  1980-06       Impact factor: 5.372

7.  Delirium tremens: a double-blind comparison of diazepam and barbital treatment.

Authors:  P Kramp; O J Rafaelsen
Journal:  Acta Psychiatr Scand       Date:  1978-08       Impact factor: 6.392

8.  The kindling hypothesis: further evidence from a U.S. national study of alcoholic men.

Authors:  B M Booth; F C Blow
Journal:  Alcohol Alcohol       Date:  1993-09       Impact factor: 2.826

9.  High-performance liquid chromatography systems for the separation of benzodiazepines and their metabolites.

Authors:  R Gill; B Law; J P Gibbs
Journal:  J Chromatogr       Date:  1986-03-28

10.  Positive relationship between the number of prior ethanol withdrawal episodes and the severity of subsequent withdrawal seizures.

Authors:  H C Becker
Journal:  Psychopharmacology (Berl)       Date:  1994-09       Impact factor: 4.530

View more
  8 in total

Review 1.  Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse.

Authors:  George R Breese; Rajita Sinha; Markus Heilig
Journal:  Pharmacol Ther       Date:  2010-10-15       Impact factor: 12.310

2.  Update on the neurobiology of alcohol withdrawal seizures.

Authors:  Michael A Rogawski
Journal:  Epilepsy Curr       Date:  2005 Nov-Dec       Impact factor: 7.500

Review 3.  Conceptual framework for the etiology of alcoholism: a "kindling"/stress hypothesis.

Authors:  George R Breese; David H Overstreet; Darin J Knapp
Journal:  Psychopharmacology (Berl)       Date:  2004-10-23       Impact factor: 4.530

4.  Levetiracetam results in increased and decreased alcohol drinking with different access procedures in C57BL/6J mice.

Authors:  Eric W Fish; Abigail E Agoglia; Michael C Krouse; R Grant Muller; J Elliott Robinson; C J Malanga
Journal:  Behav Pharmacol       Date:  2014-02       Impact factor: 2.293

Review 5.  Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management.

Authors:  Matti Hillbom; Ilkka Pieninkeroinen; Maurizio Leone
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

6.  Glutamate and benzodiazepine receptor autoradiography in rat brain after repetition of alcohol dependence.

Authors:  J Ulrichsen; B Bech; B Ebert; N H Diemer; P Allerup; R Hemmingsen
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

Review 7.  Kindling in alcohol withdrawal.

Authors:  H C Becker
Journal:  Alcohol Health Res World       Date:  1998

8.  Research Needs for Inpatient Management of Severe Alcohol Withdrawal Syndrome: An Official American Thoracic Society Research Statement.

Authors:  Tessa L Steel; Majid Afshar; Scott Edwards; Sarah E Jolley; Christine Timko; Brendan J Clark; Ivor S Douglas; Amy L Dzierba; Hayley B Gershengorn; Nicholas W Gilpin; Dwayne W Godwin; Catherine L Hough; José R Maldonado; Anuj B Mehta; Lewis S Nelson; Mayur B Patel; Darius A Rastegar; Joanna L Stollings; Boris Tabakoff; Judith A Tate; Adrian Wong; Ellen L Burnham
Journal:  Am J Respir Crit Care Med       Date:  2021-10-01       Impact factor: 21.405

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.